n from lung adenocarcinoma toР [J]. Clin Cancer Res, 2008, 14(19): 6092-6096. small cell lung cancer. A case report[J]. Oncol Lett, 2017,Р [14] Yang JJ, Chen HJ, Yan HH, et al. Clinical modes of EGFR 14(1): 593-598.Р tyrosine kinase inhibitor failure and subsequent manage- [17] Zhang SS, Bi MH. The efficiency and safety of immuneР ment in advanced non-small cell lung cancer[J]. Lung Can- checkpoint inhibitors in the treatment of small cell lungР cer, 2013, 79(1): 33-39. cancer: a meta- analysis[J]. Ann Palliat Med, 2020, 9(6):Р [15] Kato Y, Tanaka Y, Hino M, et al. ProGRP as early predic- 4081-4088.Р tive marker of non- small- cell lung cancer to small- cell （收稿日期：2021-02-05）РРР万方数据
全文预览
